Who Paid My Doc
Estelle Roberts
Optometrist, Vision Therapy Somerville, NJ Doctor of Optometry
NPI 1770537060 CMS profile 926156
205 West Main Street, Suite 307, Somerville, NJ 08876
General payments
$291
Research payments
$0
Ownership & investment interest
$0
Through program year 2021, Estelle Roberts of Somerville, NJ is reported in the CMS Open Payments database as having received $291 across 23 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 41st percentile of Optometrist, Vision Therapy profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
3 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2021 | General | $41 | 3 | |
| 2020 | General | $12 | 1 | |
| 2019 | General | $238 | 19 |
Beside peers
- Estelle Roberts
- Optometrist, Vision Therapy median
- Middle half of Optometrist, Vision Therapy
- National median
In program year 2025, general payments to Estelle Roberts were reported at $0. Among 159 Optometrist, Vision Therapy profiles paid that year, the median was $172 and the middle half received between $65 and $349.
Show as a table
| Year | Estelle Roberts | Optometrist, Vision Therapy median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $238 | $149 | $42–$361 | $163 |
| 2020 | $12 | $59 | $20–$146 | $114 |
| 2021 | $41 | $114 | $43–$217 | $132 |
| 2022 | $0 | $130 | $46–$350 | $149 |
| 2023 | $0 | $153 | $70–$363 | $160 |
| 2024 | $0 | $157 | $71–$362 | $164 |
| 2025 | $0 | $172 | $65–$349 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 6 billing codesPaid by Medicare
$8,836
Medicare patients
75
Services billed
137
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 43% | |
| Diabetes | 27% | |
| Ischemic heart disease | 23% | |
| Atrial fibrillation | 17% | |
| Depression | 15% |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
23 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Optometrist, Vision Therapy in New Jersey
Valerie Dipietro Longo
Optometrist, Vision Therapy · Turnersville, NJ
Josianne Manasse
Optometrist, Vision Therapy · East Hanover, NJ
John Diering
Optometrist, Vision Therapy · Turnersville, NJ
Kristen Vincent
Optometrist, Vision Therapy · Fair Lawn, NJ
Sarah Lane
Optometrist, Vision Therapy · Lakewood, NJ
Sonia Bassily
Optometrist, Vision Therapy · East Brunswick, NJ
Related records
Optometrist, Vision Therapy in New Jersey
Practitioners in the same specialty and state, ranked by reported value.
All Optometrist, Vision Therapy
Everyone recorded under this specialty, nationwide.
Doctors in New Jersey
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.